The performance of a rapid and sensitive single-isotope radioenzymatic assay for plasma catecholamines, in a routine clinical chemistry laboratory, is reported and discussed. The value of plasma adrenaline and noradrenaline as tumour markers in the diagnosis, tumour localisation, and post-operative follow-up of four patients with phaeochromocytoma is emphasised.
References
1.
BrownMJAllisonDJJennerDAIncreased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma adrenaline estimations and pentolinium suppression test. Lancet1981; i: 174–7.
2.
TrompeterRSDaltonNTurnerC.Plasma noradrenaline in diagnosis of phaeochromocytoma in a child. Lancet1982; i: 518.
3.
HollyJMPMakinHLJ. The estimation of catecholamines in human plasma. Analyt Biochem1983; 128: 257–74.
4.
PeulerJDJohnsonGA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci1977; 21: 625–36.
5.
Da PradaMZürcherG.Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci1976; 19: 1161–74.
6.
EllisJPJrBurnsJW. Modified handling of internal catecholamine standards in radioenzymatic assays. Clin Chem1983; 29: 144–7.
7.
BrownMJJennerDA. Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci1981; 61: 591–8.
